News

Brainwork-NavigateESUS

​NAVIGATE ESUS: Rivaroxaban vs aspirin study terminated due to comparable efficacy

2992 2000 Peter Stevenson, PhD

Early discontinuation has been announced for the Phase III NAVIGATE ESUS study – led by Bayer AG and its development partner Janssen Research & Development, LLC – which had been…

read more
Brainwork is supported by unrestricted grants from: